JP2015524391A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015524391A5 JP2015524391A5 JP2015520598A JP2015520598A JP2015524391A5 JP 2015524391 A5 JP2015524391 A5 JP 2015524391A5 JP 2015520598 A JP2015520598 A JP 2015520598A JP 2015520598 A JP2015520598 A JP 2015520598A JP 2015524391 A5 JP2015524391 A5 JP 2015524391A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- diffraction peak
- crystal form
- anhydride
- pattern
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- -1 P-3 dihydrate Chemical class 0.000 claims 20
- 239000013078 crystal Substances 0.000 claims 12
- HHFAWKCIHAUFRX-UHFFFAOYSA-N ethoxide Chemical compound CC[O-] HHFAWKCIHAUFRX-UHFFFAOYSA-N 0.000 claims 6
- BLUJRJMLDHEMRX-UHFFFAOYSA-N 2-[[2-hydroxy-5-[(5-methyltetrazol-1-yl)iminomethyl]phenyl]-(4-hydroxyphenyl)methyl]-4-[(5-methyltetrazol-1-yl)iminomethyl]phenol Chemical compound Cc1nnnn1N=Cc1ccc(O)c(c1)C(c1ccc(O)cc1)c1cc(C=Nn2nnnc2C)ccc1O BLUJRJMLDHEMRX-UHFFFAOYSA-N 0.000 claims 5
- 241000700605 Viruses Species 0.000 claims 2
- 150000004683 dihydrates Chemical class 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 150000004682 monohydrates Chemical class 0.000 claims 2
- 208000024891 symptom Diseases 0.000 claims 2
- 206010006448 Bronchiolitis Diseases 0.000 claims 1
- 206010033078 Otitis media Diseases 0.000 claims 1
- 206010035664 Pneumonia Diseases 0.000 claims 1
- 241000711902 Pneumovirus Species 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000036039 immunity Effects 0.000 claims 1
- 206010039083 rhinitis Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261666258P | 2012-06-29 | 2012-06-29 | |
| US61/666,258 | 2012-06-29 | ||
| PCT/US2013/048723 WO2014005098A2 (en) | 2012-06-29 | 2013-06-28 | Compositions and methods for treating or preventing pneumovirus infection and associated diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015524391A JP2015524391A (ja) | 2015-08-24 |
| JP2015524391A5 true JP2015524391A5 (enExample) | 2016-08-18 |
Family
ID=49778754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015520598A Withdrawn JP2015524391A (ja) | 2012-06-29 | 2013-06-28 | ニューモウイルス感染症および感染疾患を治療あるいは予防するための組成物および方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US9040569B2 (enExample) |
| EP (1) | EP2867216A4 (enExample) |
| JP (1) | JP2015524391A (enExample) |
| KR (1) | KR20150037946A (enExample) |
| CN (1) | CN104507918A (enExample) |
| AU (1) | AU2013282286A1 (enExample) |
| BR (1) | BR112014032290A2 (enExample) |
| CA (1) | CA2877941A1 (enExample) |
| EA (1) | EA201590124A1 (enExample) |
| HK (2) | HK1203956A1 (enExample) |
| IL (1) | IL236476A0 (enExample) |
| IN (1) | IN2014DN10680A (enExample) |
| MX (1) | MX2014015340A (enExample) |
| NZ (1) | NZ628880A (enExample) |
| TW (1) | TWI516283B (enExample) |
| WO (1) | WO2014005098A2 (enExample) |
| ZA (1) | ZA201409073B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2867216A4 (en) | 2012-06-29 | 2015-12-09 | Microdose Therapeutx Inc | COMPOSITIONS AND METHODS OF TREATING PNEUMOVIRAL INFECTIONS AND ASSOCIATED DISEASES |
| EP3233807B1 (de) * | 2014-12-18 | 2019-09-04 | MetrioPharm AG | Kristalline form von 5-amino-2,3-dihydrophthalazin-1,4-dion natriumsalz, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung |
| JP2018535277A (ja) * | 2015-11-30 | 2018-11-29 | ノヴァス・セラピューティクス・インコーポレーテッド | 耳科学的予防および処置のための組成物および方法 |
| WO2018071445A1 (en) | 2016-10-11 | 2018-04-19 | Microdose Therapeutx, Inc. | Inhaler and methods of use thereof |
| MX2021001820A (es) * | 2018-09-14 | 2021-04-28 | Pharmosa Biopharm Inc | Composicion farmaceutica para la liberacion controlada de farmacos acidos debiles y usos de los mismos. |
| CN109827875A (zh) * | 2019-04-10 | 2019-05-31 | 上海市食品药品检验所 | 一种用于测定吸入制剂溶出度的装置和方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6495580B1 (en) * | 1998-01-29 | 2002-12-17 | Viropharma Incorporated | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| WO1999038508A1 (en) | 1998-01-29 | 1999-08-05 | Viropharma Incorporated | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| WO2002059132A1 (en) | 2001-01-26 | 2002-08-01 | Viropharma Incorporated | Intermediate compounds useful for making antiviral compounds |
| EP1545513A2 (en) | 2002-08-09 | 2005-06-29 | Viropharma Incorporated | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| EP1539691A2 (en) | 2002-08-09 | 2005-06-15 | Viropharma Incorporated | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| EP2867216A4 (en) | 2012-06-29 | 2015-12-09 | Microdose Therapeutx Inc | COMPOSITIONS AND METHODS OF TREATING PNEUMOVIRAL INFECTIONS AND ASSOCIATED DISEASES |
-
2013
- 2013-06-28 EP EP13809282.0A patent/EP2867216A4/en not_active Withdrawn
- 2013-06-28 HK HK15104634.7A patent/HK1203956A1/xx unknown
- 2013-06-28 CN CN201380034589.0A patent/CN104507918A/zh active Pending
- 2013-06-28 HK HK15110967.1A patent/HK1210163A1/xx unknown
- 2013-06-28 NZ NZ628880A patent/NZ628880A/en not_active IP Right Cessation
- 2013-06-28 US US13/931,201 patent/US9040569B2/en not_active Expired - Fee Related
- 2013-06-28 WO PCT/US2013/048723 patent/WO2014005098A2/en not_active Ceased
- 2013-06-28 EA EA201590124A patent/EA201590124A1/ru unknown
- 2013-06-28 JP JP2015520598A patent/JP2015524391A/ja not_active Withdrawn
- 2013-06-28 CA CA2877941A patent/CA2877941A1/en not_active Abandoned
- 2013-06-28 KR KR20157002571A patent/KR20150037946A/ko not_active Withdrawn
- 2013-06-28 AU AU2013282286A patent/AU2013282286A1/en not_active Abandoned
- 2013-06-28 IN IN10680DEN2014 patent/IN2014DN10680A/en unknown
- 2013-06-28 MX MX2014015340A patent/MX2014015340A/es unknown
- 2013-06-28 BR BR112014032290A patent/BR112014032290A2/pt not_active IP Right Cessation
- 2013-07-01 TW TW102123484A patent/TWI516283B/zh not_active IP Right Cessation
-
2014
- 2014-12-10 ZA ZA2014/09073A patent/ZA201409073B/en unknown
- 2014-12-25 IL IL236476A patent/IL236476A0/en unknown
-
2015
- 2015-04-10 US US14/683,935 patent/US9504672B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015524391A5 (enExample) | ||
| EA201591390A1 (ru) | Пиразол[1,5-a]пиримидины для противовирусного лечения | |
| NZ701647A (en) | Compounds and methods for antiviral treatment | |
| CA2818938A1 (en) | Compounds for treating respiratory syncytial virus infections | |
| AU2012358805A8 (en) | Pyrazolo[1,5-a]pyrimidines as antiviral agents | |
| AP3103A (en) | Derivatives of purine or deazapurine useful for the treatment of (inter alia)viral infections | |
| ATE541845T1 (de) | 2,3-substituierte azaindolderivate zur behandlung von virusinfektionen | |
| JP2015512931A5 (enExample) | ||
| WO2012027712A3 (en) | Potent and selective inhibitors of hepatitis c virus | |
| IL227990B (en) | Use of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl) piperidine-2,6-dione for preparation of medicaments for treatment of immune-related and inflammatory diseases | |
| EA201100613A1 (ru) | Конденсированные, спироциклические гетероароматические соединения для лечения бактериальных инфекций | |
| ES2855159T8 (es) | Tratamiento de las infecciones pulmonares mediante administración de tobramicina por aerolización | |
| HUE036220T2 (hu) | Kinazolin származékok vírusfertõzések és további betegségek kezelésére | |
| WO2011158042A3 (en) | Ureido- pyrazole derivatives for use in the treatment of rhinovirus infections | |
| UA111163C2 (uk) | Способи й сполуки для лікування вірусних інфекцій paramyxoviridae | |
| EP2760479A4 (en) | METHOD FOR THE THERAPEUTIC MONITORING OF NITROGEN ABSORPTION ACTIVE SUBSTANCES | |
| WO2013055258A3 (ru) | Применение глутарилгистамина для лечения заболеваний дыхательных путей | |
| CL2013002031A1 (es) | Dimaleato de 9-[4-(3-cloro-2-fluoro-fenilamino)-7-metoxi-quinazolin-6-il oxi]-1-metil-1,4-diaza-espiro[5.5]undecan-5-ona; forma cristalina; compuestos intermediarios; procedimiento de preparacion; composicion y combinacion farmaceutica; y su uso para tratar enfermedades infecciosas o alergicas de las vias respiratorias. | |
| TW201613931A (en) | Form crystal of bisulfate of janus kinase (JAK) inhibitor and preparation method thereof | |
| IN2012DN06678A (enExample) | ||
| WO2010135170A3 (en) | Nitrile derivatives and their pharmaceutical use and compositions | |
| WO2014005098A3 (en) | Compositions and methods for treating or preventing pneumovirus infection and associated diseases | |
| MX2013002956A (es) | Arilsulfonamidas para el tratamiento de enfermedades del sistema nervioso central. | |
| PL2291374T3 (pl) | Sposób wytwarzania solifenacyny i/lub jej farmaceutycznie dopuszczalnych soli o wysokiej czystości farmaceutycznej | |
| WO2012122450A3 (en) | Peptide deformylase inhibitors |